Secondary prevention of myocardial infarction

A survey in primary care

Alessandro Filippi, Diego Vanuzzo, Angelo A. Bignamini, Gianpiero Mazzaglia, Ovidio Brignoli, Andrea Sabatini, Claudio Cricelli, Alberico L. Catapano

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

OBJECTIVE: To collect information on the major risk factors and secondary prevention among patients with myocardial infarction in Italy. METHODS: Data were obtained from the database of the Italian College of General Practitioners; 3588 patients (mean age 68.7 ± 11.3 years; 2698 men, 888 women; two unrecorded gender), with an average time from event of 6 ± 5.7 years, were identified. RESULTS: Among the major risk factors, data entry ranged from 50.3% for physical activity to 74.9% for blood pressure. Inadequate blood pressure control was present in 49.2% and elevated plasma cholesterol levels (> 5.2 mmol/l) in 57.3%; among the latter group, 65% were on lipid-lowering therapy. Only 47.2% of the treated patients achieved a total cholesterol level of <5.2 mmol/l. Antiplatelet or anticoagulant drugs, β-blockers, and angiotensin-converting enzyme inhibitors were prescribed to 43%, 10.3%, and 57.9% of patients, respectively. CONCLUSIONS: The preventive attitude of Italian general practitioners is similar to that reported in other European countries with two noticeable exceptions: under-prescription of β-blockers and of antiplatelet drugs. Clearly, secondary prevention requires major improvement.

Original languageEnglish
Pages (from-to)422-426
Number of pages5
JournalJournal of Cardiovascular Medicine
Volume7
Issue number6
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Secondary Prevention
Primary Health Care
Myocardial Infarction
Platelet Aggregation Inhibitors
General Practitioners
Blood Pressure
Hypercholesterolemia
Angiotensin-Converting Enzyme Inhibitors
Anticoagulants
Italy
Prescriptions
Cholesterol
Databases
Exercise
Lipids
Surveys and Questionnaires
Therapeutics

Keywords

  • Cholesterol
  • Myocardial infarction
  • Risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Secondary prevention of myocardial infarction : A survey in primary care. / Filippi, Alessandro; Vanuzzo, Diego; Bignamini, Angelo A.; Mazzaglia, Gianpiero; Brignoli, Ovidio; Sabatini, Andrea; Cricelli, Claudio; Catapano, Alberico L.

In: Journal of Cardiovascular Medicine, Vol. 7, No. 6, 06.2006, p. 422-426.

Research output: Contribution to journalArticle

Filippi, A, Vanuzzo, D, Bignamini, AA, Mazzaglia, G, Brignoli, O, Sabatini, A, Cricelli, C & Catapano, AL 2006, 'Secondary prevention of myocardial infarction: A survey in primary care', Journal of Cardiovascular Medicine, vol. 7, no. 6, pp. 422-426. https://doi.org/10.2459/01.JCM.0000228693.07279.a1
Filippi A, Vanuzzo D, Bignamini AA, Mazzaglia G, Brignoli O, Sabatini A et al. Secondary prevention of myocardial infarction: A survey in primary care. Journal of Cardiovascular Medicine. 2006 Jun;7(6):422-426. https://doi.org/10.2459/01.JCM.0000228693.07279.a1
Filippi, Alessandro ; Vanuzzo, Diego ; Bignamini, Angelo A. ; Mazzaglia, Gianpiero ; Brignoli, Ovidio ; Sabatini, Andrea ; Cricelli, Claudio ; Catapano, Alberico L. / Secondary prevention of myocardial infarction : A survey in primary care. In: Journal of Cardiovascular Medicine. 2006 ; Vol. 7, No. 6. pp. 422-426.
@article{0828fbb3985041e898d68ae81ee20b9b,
title = "Secondary prevention of myocardial infarction: A survey in primary care",
abstract = "OBJECTIVE: To collect information on the major risk factors and secondary prevention among patients with myocardial infarction in Italy. METHODS: Data were obtained from the database of the Italian College of General Practitioners; 3588 patients (mean age 68.7 ± 11.3 years; 2698 men, 888 women; two unrecorded gender), with an average time from event of 6 ± 5.7 years, were identified. RESULTS: Among the major risk factors, data entry ranged from 50.3{\%} for physical activity to 74.9{\%} for blood pressure. Inadequate blood pressure control was present in 49.2{\%} and elevated plasma cholesterol levels (> 5.2 mmol/l) in 57.3{\%}; among the latter group, 65{\%} were on lipid-lowering therapy. Only 47.2{\%} of the treated patients achieved a total cholesterol level of <5.2 mmol/l. Antiplatelet or anticoagulant drugs, β-blockers, and angiotensin-converting enzyme inhibitors were prescribed to 43{\%}, 10.3{\%}, and 57.9{\%} of patients, respectively. CONCLUSIONS: The preventive attitude of Italian general practitioners is similar to that reported in other European countries with two noticeable exceptions: under-prescription of β-blockers and of antiplatelet drugs. Clearly, secondary prevention requires major improvement.",
keywords = "Cholesterol, Myocardial infarction, Risk factors",
author = "Alessandro Filippi and Diego Vanuzzo and Bignamini, {Angelo A.} and Gianpiero Mazzaglia and Ovidio Brignoli and Andrea Sabatini and Claudio Cricelli and Catapano, {Alberico L.}",
year = "2006",
month = "6",
doi = "10.2459/01.JCM.0000228693.07279.a1",
language = "English",
volume = "7",
pages = "422--426",
journal = "Journal of Cardiovascular Medicine",
issn = "1558-2027",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Secondary prevention of myocardial infarction

T2 - A survey in primary care

AU - Filippi, Alessandro

AU - Vanuzzo, Diego

AU - Bignamini, Angelo A.

AU - Mazzaglia, Gianpiero

AU - Brignoli, Ovidio

AU - Sabatini, Andrea

AU - Cricelli, Claudio

AU - Catapano, Alberico L.

PY - 2006/6

Y1 - 2006/6

N2 - OBJECTIVE: To collect information on the major risk factors and secondary prevention among patients with myocardial infarction in Italy. METHODS: Data were obtained from the database of the Italian College of General Practitioners; 3588 patients (mean age 68.7 ± 11.3 years; 2698 men, 888 women; two unrecorded gender), with an average time from event of 6 ± 5.7 years, were identified. RESULTS: Among the major risk factors, data entry ranged from 50.3% for physical activity to 74.9% for blood pressure. Inadequate blood pressure control was present in 49.2% and elevated plasma cholesterol levels (> 5.2 mmol/l) in 57.3%; among the latter group, 65% were on lipid-lowering therapy. Only 47.2% of the treated patients achieved a total cholesterol level of <5.2 mmol/l. Antiplatelet or anticoagulant drugs, β-blockers, and angiotensin-converting enzyme inhibitors were prescribed to 43%, 10.3%, and 57.9% of patients, respectively. CONCLUSIONS: The preventive attitude of Italian general practitioners is similar to that reported in other European countries with two noticeable exceptions: under-prescription of β-blockers and of antiplatelet drugs. Clearly, secondary prevention requires major improvement.

AB - OBJECTIVE: To collect information on the major risk factors and secondary prevention among patients with myocardial infarction in Italy. METHODS: Data were obtained from the database of the Italian College of General Practitioners; 3588 patients (mean age 68.7 ± 11.3 years; 2698 men, 888 women; two unrecorded gender), with an average time from event of 6 ± 5.7 years, were identified. RESULTS: Among the major risk factors, data entry ranged from 50.3% for physical activity to 74.9% for blood pressure. Inadequate blood pressure control was present in 49.2% and elevated plasma cholesterol levels (> 5.2 mmol/l) in 57.3%; among the latter group, 65% were on lipid-lowering therapy. Only 47.2% of the treated patients achieved a total cholesterol level of <5.2 mmol/l. Antiplatelet or anticoagulant drugs, β-blockers, and angiotensin-converting enzyme inhibitors were prescribed to 43%, 10.3%, and 57.9% of patients, respectively. CONCLUSIONS: The preventive attitude of Italian general practitioners is similar to that reported in other European countries with two noticeable exceptions: under-prescription of β-blockers and of antiplatelet drugs. Clearly, secondary prevention requires major improvement.

KW - Cholesterol

KW - Myocardial infarction

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=33746587034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746587034&partnerID=8YFLogxK

U2 - 10.2459/01.JCM.0000228693.07279.a1

DO - 10.2459/01.JCM.0000228693.07279.a1

M3 - Article

VL - 7

SP - 422

EP - 426

JO - Journal of Cardiovascular Medicine

JF - Journal of Cardiovascular Medicine

SN - 1558-2027

IS - 6

ER -